Biotech RenovaCare Can't Beat Investors' Stock Promo Suit

By Katryna Perera · June 4, 2024, 10:05 PM EDT

A New Jersey federal judge has ruled that investors in biotechnology company RenovaCare Inc. failed to prove their case against firms they accused of profiting from a scheme to pump up the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Opinion

Case Information

Case Title

In Re RenovaCare, Inc. Securities Litigation

Case Number

Court

New Jersey

Nature of Suit

Securities/Commodities

Date Filed

July 16, 2021

Recent Articles By Katryna

July 01, 2024
Delta Dental Wants Antitrust Claims Standard Decided Now
June 06, 2024
White Collar Boutique Sued By Ex-Client Over Representation
June 03, 2024
Humana Hit With Investor Suit Over Post-COVID Costs
May 30, 2024
Veradigm Execs Sued Over Company's Nasdaq Delisting
May 20, 2024
iRhythm Brass Face Suit Over FDA's Heart Monitor Inquiry
May 02, 2024
Masimo Hit With Derivative Suit Over Audio Co. Acquisition
May 01, 2024
Insulin Pump Maker Wins Toss of Investor Suit For Now
April 30, 2024
Vaxart Investors Want Sanctions Over Deleted Texts
April 08, 2024
Walmart Beats Investor Suit Over Opioid Probe Disclosures
March 29, 2024
Hedge Fund Beats Vaxart Investor's 'Short-Swing' Profits Suit